Company Profile: Evidera

Discussion in 'Lab News and Update' started by admin, Feb 11, 2019 at 2:55 PM.

  1. admin

    admin Administrator Staff Member

    Joined:
    Sep 27, 2005
    Messages:
    108,483
    Likes Received:
    3
    Trophy Points:
    38
    Company profile: Evidera
    [​IMG]

    Data disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success.

    For years one of the pharmaceutical industry’s biggest challenges has been converting the promise of results gained in a clinical trial setting into success in the real world. Are payers willing to pay for the treatment? Will the product show the same benefit to patients outside of a controlled scenario? What is the evidence that supports that the product has true value in the real world?

    pharmaphorum spoke with Dr Radek Wasiak, VP and global head of peri- and post-approval studies at Evidera, a PPD business unit, to get his perspective on the changing dynamics and impact of data generation and analysis in the world of healthcare.

    • Read the article in full in pharmaphorum’s Deep Dive digital magazine


    The post Company profile: Evidera appeared first on Pharmaphorum.
     

Share This Page